Anaptysbio (ANAB) Revenue (2016 - 2026)
Anaptysbio (ANAB) reported Revenue of $25.56 million for Q1 2026, down 8.0% from $27.77 million a year earlier and down 76.4% from the prior quarter.
Powered by 
Analysis
Anaptysbio (ANAB) Revenue (2016 - 2026) Analysis & Trends
Over the twelve months ended Mar 31, 2026, Anaptysbio's Revenue came in at $232.39 million, up 107.7% year-over-year; for FY2025, it was $234.6 million, up 157.0% from FY2024.
- Revenue has increased for three consecutive years, with a five-year compound annual growth rate of 25.6% (FY2020 to FY2025).
- By year, Revenue came in at $91.28 million in FY2024 (+432.0%), $17.16 million in FY2023 (+66.8%), $10.29 million in FY2022 (-83.7%) and $63.18 million in FY2021 (-15.8%).
- Five-year quarterly Revenue spans a low of $970,000 in Q1 2022 and a high of $108.25 million in Q4 2025.
- Year over year, Revenue gained in seven of the last eight quarters, with growth averaging 261.0%.
- The high point for year-over-year Revenue in five years was Q3 2024 (growth of 804.7%); the low point was Q4 2021 (a decline of 98.3%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $108.25 million (Q4 2025), $76.32 million (Q3 2025) and $22.26 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Anaptysbio | 1.41 Bn | 296.12 Mn | - | 25.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 25.56 Mn |
| Dec 31, 2025 | 108.25 Mn |
| Sep 30, 2025 | 76.32 Mn |
| Jun 30, 2025 | 22.26 Mn |
| Mar 31, 2025 | 27.77 Mn |
| Dec 31, 2024 | 43.11 Mn |
| Sep 30, 2024 | 30.02 Mn |
| Jun 30, 2024 | 10.97 Mn |
| Mar 31, 2024 | 7.18 Mn |
| Dec 31, 2023 | 9.01 Mn |
| Sep 30, 2023 | 3.32 Mn |
| Jun 30, 2023 | 3.46 Mn |
| Mar 31, 2023 | 1.37 Mn |
| Dec 31, 2022 | 6.81 Mn |
| Sep 30, 2022 | 1.29 Mn |
| Jun 30, 2022 | 1.22 Mn |
| Mar 31, 2022 | 970,000.00 |
| Dec 31, 2021 | 1.01 Mn |
| Sep 30, 2021 | 20.89 Mn |
| Jun 30, 2021 | 30.03 Mn |
API Access
Anaptysbio Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ANAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ANAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ANAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();